Last reviewed: June 11, 2026

Last updated: June 11, 2026

Written by: Jay Hastings, CEO of PlexusDx

Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance.

Medically reviewed by: Jayden Lee, PharmD, EMBA

Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.

This article is part of the PlexusDx Education Hub — science-backed guidance on GLP-1 medications, metabolic health, and precision weight management.

Semaglutide, the active ingredient in Ozempic, works by mimicking glucagon-like peptide-1 (GLP-1), a hormone that controls hunger and blood sugar. Recent clinical trials demonstrate that patients taking semaglutide lose significantly more weight than those taking placebo alone. PlexusDx offers compounded semaglutide injections starting at $149 per month from licensed 503A pharmacies, making this proven therapy accessible across all 50 states without insurance.

Typical Semaglutide Weight Loss Results in Clinical Trials

The STEP program, a landmark clinical trial series, tracked semaglutide's weight-loss effects in over 4,500 patients over 68 weeks. Participants receiving the highest dose lost an average of 15–17% of their starting body weight, compared to 2–3% in the placebo group. These results represent one of the most significant weight reductions ever documented in obesity research, positioning semaglutide as a game-changing medication for patients struggling with traditional diet and exercise approaches.

Individual weight loss on semaglutide ranges from 10–22% depending on starting body weight, dose adherence, and metabolic factors. A patient weighing 250 pounds might lose 25–55 pounds over a year of consistent treatment, though these outcomes vary widely. Factors like age, insulin resistance, physical activity level, and dietary choices influence the total amount of weight each person loses, making personalized tracking essential for measuring success.

How Semaglutide Triggers Weight Loss at the Cellular Level

Semaglutide activates GLP-1 receptors in the brain's hypothalamus, the control center for hunger signals and satiety. When these receptors are stimulated, the brain receives stronger 'fullness' signals, reducing calorie intake naturally and dramatically. Patients typically report eating smaller portions, feeling satisfied longer, and experiencing fewer cravings for high-calorie foods within the first few weeks of treatment.

Beyond appetite suppression, semaglutide slows gastric emptying—the rate at which food moves from the stomach into the small intestine. This delayed digestion creates sustained fullness, preventing the rapid energy crashes that typically trigger overeating. Additionally, semaglutide may increase fat oxidation (the body's ability to burn stored fat for energy), contributing to the observed weight loss independent of calorie restriction alone.

Factors That Influence How Much Weight You'll Lose

Genetic predisposition plays a critical role in semaglutide response. Variations in the GLP1R gene (rs6923761) and GIPR gene (rs1800437) influence how effectively your body responds to the medication. PlexusDx's Precision Peptide Genetic Test maps 14 metabolic pathways and analyzes 150+ genetic insights to predict your peptide-pathway response, helping personalize your treatment plan before you begin therapy.

Adherence and dose progression directly impact weight-loss outcomes. Patients who take their injection consistently every week and gradually increase to their target dose lose more weight than those with inconsistent dosing. Lifestyle factors including sleep quality, stress levels, and physical activity also influence results; those maintaining regular exercise and adequate sleep typically see enhanced weight loss compared to sedentary patients on the same dose.

Semaglutide vs. Other GLP-1 Medications: Weight Loss Comparison

Head-to-head comparisons show semaglutide produces sustained weight loss comparable to other GLP-1 agonists like dulaglutide and liraglutide, though individual response varies. Tirzepatide, a newer dual GLP-1/GIP receptor agonist, demonstrates slightly greater weight loss (up to 22%) in some trials, but semaglutide remains the most studied and accessible option. PlexusDx offers both compounded semaglutide injections ($149/mo) and tirzepatide ($249/mo), allowing patients and providers to choose based on clinical response and preference.

Oral semaglutide tablets require higher doses to achieve similar results as injections due to absorption challenges in the digestive tract. Many patients prefer injections because they deliver the medication directly into the bloodstream, enabling lower doses and more consistent weight loss. PlexusDx provides both formats—oral semaglutide and compounded semaglutide injections—so patients can select the administration method that fits their lifestyle and comfort level.

Timeline: When to Expect Weight Loss on Semaglutide

Weight loss typically becomes noticeable within the first 4–8 weeks of semaglutide treatment as doses are gradually increased. Most patients report decreased hunger and reduced portion sizes by week 2–3, though the scale may not shift immediately. By week 8–12, meaningful weight loss (5–10 pounds) becomes evident in many patients, with continued steady loss through month 6 and beyond as the dose reaches therapeutic levels.

Plateaus are common during months 4–6 as the body adapts to the medication and achieves a new metabolic balance. This does not mean the treatment is failing; rather, it reflects the body's natural regulatory response. Continuing treatment, maintaining dietary consistency, and sustaining physical activity typically allow weight loss to resume. Long-term studies show weight loss continues and stabilizes over 12–24 months with ongoing semaglutide therapy.

How Your Genetics Influence GLP-1 Response

Not everyone responds to GLP-1 medications the same way. Genetic variants — including GIPR rs1800437, GLP1R rs6923761, FTO rs9939609, and MC4R rs17782313 — influence how your body processes these medications, how much weight you lose, and how you tolerate side effects. PlexusDx maps 14 pathways, 49 peptides, and 150+ genetic insights to match each patient to the right medication, dose, and lifestyle protocol for their biology. The PlexusDx Precision Peptide Genetic Test ($99 add-on after your first month of treatment) gives your provider precise insight into your peptide genetic predispositions before the first prescription is written.

Access Personalized GLP-1 Care Through PlexusDx

PlexusDx offers six prescription GLP-1 protocols to all 50 states — no membership, no insurance required, async intake or live consult. The Semaglutide Injection starts at $149/mo. Medications are dispensed from licensed 503A compounding pharmacies following strict quality and safety standards. Add a Precision Peptide Genetic Test for $99 to personalize your protocol from day one.

Frequently Asked Questions

How much weight will I lose if I take semaglutide for 6 months?

Based on clinical trial data, most patients lose 15–20 pounds in the first 6 months, though outcomes range from 10–40+ pounds depending on starting weight, dose, and lifestyle factors. PlexusDx's Precision Peptide Genetic Test can help predict your individual response by analyzing genetic variants in the GLP1R and GIPR pathways before treatment begins.

Is semaglutide weight loss permanent, or do people regain it?

Weight loss is sustained as long as you continue semaglutide therapy; studies show weight regain occurs when treatment stops. However, many patients maintain a significant portion of their lost weight through lifestyle changes built during treatment. Long-term semaglutide use (beyond 2 years) remains safe and effective for weight maintenance, with PlexusDx offering ongoing support across all 50 states.

How much does compounded semaglutide cost at PlexusDx?

PlexusDx offers compounded semaglutide injections from licensed 503A pharmacies starting at $149 per month, with no insurance required and HSA/FSA eligibility. Your dose may need to go up as treatment progresses, but your price won't—flat monthly pricing applies regardless of dose level.

What side effects might slow or prevent weight loss?

Gastrointestinal side effects (nausea, constipation, diarrhea) are most common and usually resolve within 2–4 weeks. These effects may reduce appetite further, enhancing weight loss in some patients, while others may eat less due to discomfort rather than satiety. Staying hydrated, eating smaller frequent meals, and taking medication as directed minimizes side effects and optimizes weight-loss outcomes.

Can the Precision Peptide Genetic Test predict my semaglutide results?

Yes. PlexusDx's Precision Peptide Genetic Test ($99 add-on after your first month) analyzes 14 metabolic pathways and 150+ genetic insights, including GLP1R and GIPR variants that directly influence how your body responds to semaglutide. This personalized data helps optimize your dose and predict weight-loss potential before months of treatment.

Related Reading

Pricing and availability current as of June 2026. Compounded GLP-1 medications are not FDA-approved drug products; they are prepared by licensed compounding pharmacies under federal compounding regulations. Compounded semaglutide and tirzepatide are not the same as Wegovy, Ozempic, Zepbound, or Mounjaro. This article is for informational purposes only and does not constitute medical advice. Consult a licensed healthcare provider before starting, stopping, or changing any medication.

Return to the PlexusDx Education Hub for more evidence-based resources on GLP-1 therapy, metabolic health, and personalized weight management.

Medical and Editorial Standards

Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.

Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance.

Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.

Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.

Real prescribers. Published prices. No surprises.

Licensed providers in all 50 states. Online intake. No insurance, no membership required.

Start My Intake →

~60 seconds · $0 charged until your provider approves